Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to ...

Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of targeted protein degrader therapies, today announced its attendance at ...

TNL Mediagene's subsidiary Infobahn has been selected as a Lead Partner for the Ministry of Economy, Trade and Industry of ...

WILMINGTON, Del., Jan. 07, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be ...

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and ...

Programmers hold to a wide spectrum of positions on software complexity, from the rare command-line purists to the much more ...

However, there is a major limitation here. Unlike Copilot in PowerPoint, Google Slides can't create an entire presentation ...

I found the top 8 AI website builders that don't require any coding knowledge and you can publish your website in just one ...

NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...

Vepdegestrant is an investigational, orally bioavailable PROTAC estrogen receptor degrader. In the VERITAC-2 Phase 3 study, vepdegestrant demonstrated statistically significant and clinically ...

What’s happened? If you dread building slide decks, Google just made it a cakewalk to turn your files or ideas into a presentation. In its latest update, Gemini’s Canvas can now generate complete ...